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Integrin expression and IgA nephropathy: In vitro modulation tion of changes in the cellular environment and the inte-
by IgA with altered glycosylation and macromolecular IgA. gration of such signals within MCs evokes enzymatic
Background. Signal transduction by mesangial cell (MC) modifications of the mesangial matrix [2]. The cross-talkintegrins regulates cell growth and survival, extracellular matrix
between MCs and the surrounding matrix is mediatedproduction, and organization. The aim of the study was to investi-
by specific proteins, collectively called integrins. Integ-gate human MC integrin modulation by differently glycosylated
IgA and macromolecular IgA, which are thought to play a patho- rins are heterodimers of a and b subunits that form, in
genetic role in IgA nephropathy (IgAN). various combinations, a large number of receptors that
Methods. MCs were incubated with purified human poly-
are capable of binding one or more ligands [3, 4]. Eachmeric IgA, heat-aggregated IgA, IgA glycoforms generated by
integrin displays a ligand-binding site that recognizes spe-enzymatic hydrolysis of saccharide residues and serum fractions
from IgAN patients, and controls isolated by lectin affinity and cific amino acid sequences of several extracellular matrix
containing IgA with peculiar glycan patterns. Integrins were proteins, including fibrinogen, fibronectin, thrombospon-
quantitated by flow cytometry. din, vitronectin, laminin, and the collagens. The bindingResults. Cultured MCs highly expressed avb3 and some a3b1; to the appropriate extracellular matrix activates the cyto-avb3 was up-regulated by matrix components (P , 0.02). In
plasmic domain of the b integrin, producing a cascade ofvitro desialylated and degalactosylated polymeric human IgA
enhanced avb3 expression on cultured MCs (P , 0.001). Serum signals that influences a wide range of cellular functions,
IgA glycoforms isolated from IgAN patients with high expo- spanning from reorganization of the cytoskeleton to con-
sure of internal sugars, GalNAc, Neu5Ac2,6GalNAc, and Man trol of gene expression [reviewed in 5]. In particular,enhanced av expression on cultured MCs more than healthy
integrin-mediated signal transduction modulates the path-controls.
ways controlling cell growth and survival. Cell adhesionConclusions. These data support the hypothesis that IgA gly-
cation plays a role in modulating the cell–matrix interaction, and spreading activate mitogen-activated protein kinase
and that this mechanism can be operating in IgAN. via Ras-dependent and -independent pathways, with con-
sequent cell cycle modulation [6, 7]. On the other hand,
whereas engagement of integrin with the matrix pro-
Mesangial cell (MC) activity modulates the develop- motes cell proliferation, in the absence of ligand, integ-
ment and evolution of IgA nephropathy (IgAN) [1]. The rins block cell proliferation and down-regulate the ex-
MC activation, likely triggered by IgA deposition in the pression of c-fos and c-jun early genes [6–8].
mesangium, is closely regulated by interactions between Human MCs in culture express a3b1 and avb3 integrins
these cells and their environment. In turn, the transduc- [2, 9–12]. These transmembrane proteins are likely to
play a pivotal role in several critical functions of MCs,
modulating cell growth, survival, and differentiation [13].
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the cytoskeleton of MCs to the extracellular matrix, in- human to laboratory animal species, which are provided
with marked variation in IgA biology [16].tegrins may participate in linking the contraction of MCs
Herein, we speculate on the possible role of integrinto the regulation of glomerular hemodynamics and the
modulation by aberrantly glycosylated IgA in the devel-filtration properties of the glomerular capillaries [2].
opment and evolution of IgAN.The expression of several b1 integrins (a1, a2, a3, a5,
and a8) was demonstrated not only in cultured MCs but
also in normal human kidney tissue [13]; however, a3b1 METHODS
was found by immunoelectron microscopy exclusively
Experimental planon visceral and capsular epithelial cells. Similarly, avb3
The expression of integrins on MCs after incubationwas detected in normal kidney mostly along the glomeru-
with each of several selected stimuli was compared withlar capillary wall. Since some avb3 reactivity also was
that on MCs maintained in a standard cultured medium.found in the mesangial area and the avb3 ligand, vitronec-
In a first series of experiments, MC culture mediumtin, was seen exclusively in the mesangium, interest has
was implemented with 10 to 30 mg/mL of purified humanrecently been focused on MC avb3 integrin [13].
fibronectin (Sigma Chemical Co., St. Louis, MO, USA),Several functional roles of mesangial integrins, includ-
thus increasing the fibronectin concentration of cultureing the transmission of contractile forces to the glomeru-
medium by 0.5 to 1.5 times. The effects of supplementa-lar basement membrane and the regulation of cell prolif-
tion of the culture medium with human type IV collageneration and matrix metabolism, may be relevant for the
10 mg/mL were examined (Sigma). Several preparationsdevelopment and evolution of IgAN. Accordingly, our
of purified human IgA, including polymeric IgA (Sigmastudy was aimed to explore mesangial integrins in IgAN,
from human cholostrum) and heat-aggregated polymericfocusing on factors modulating avb3 expression.
IgA, prepared by heating the polymeric IgA 20 mg/mLGlycosylation of the protein chains greatly influences
at 638C for 120 minutes [26], each at a concentration ofthe functional properties of adhesion molecules, including
50 mg/mL were employed as test stimuli in a subsequentintegrins and their matrix ligands [14, 15]. On the other
series of experiments. Moreover, abnormal glycoformshand, IgAs are highly glycosylated molecules [16]. Carbo-
of IgA, rich in terminal Gal/Gal NAc or in GalNAc boundhydrates represent 12% in serum IgA and 15% in secre-
in 2,6 to Neu5Ac, typical sugars of O-linked chains, or intory IgA. Human IgA1 contains two potential N-linked
Man, typical sugar of N-linked chains, were isolated fromglycosylation sites and five O-linked sites in the hinge
IgAN patients’ sera by sequential lectin affinity and gelregion of each chain. Each O-glycan has a core N-acetyl-
filtration chromatography (vide infra). In these experi-galactosamine (GalNAc) linked in b1,3 to galactose (Gal) ments, parallel MC cultures were incubated with Neu5Ac,
and with one or two sialic acid (Neu5Ac) units in a2,3 GalNAc, or Man, each at a 0.1 mol/L concentration.
linkage with Gal or a2,6 linkage with GalNAc [17]. IgA2 Finally, in a third round of experiments, abnormal
lacks these O-linked sugars, but the IgA2m allotype has glycoforms of IgA were generated enzymatically by treat-
two extra N-linked sites [17]. ment of normal human polymeric IgA with selected endo-
During the last years, several groups have demon- glycosidases (vide infra). The desialylation and degalac-
strated an aberrant glycosylation of serum IgA in IgAN tosylation were not done in patient samples because of
patients [18–20]. We previously found that IgA from the limited amount of serum available. In all cases, stim-
patients with IgAN has increased binding to some lectins uli tested by the LAL test (standard Escherichia coli
[18] and to matrix components [19], and that this binding III:B4; Kabi, Stockholm, Sweden) to ensure endotoxin-
was due to carbohydrate interactions [20]; moreover, free conditions were added to the same supplemented
we found that these properties characterize transplanted culture medium used to maintain the cell in culture (dis-
IgAN patients with recurrency of IgAN [21]. In patients cussed later in this article), in a humidified atmosphere
with IgAN, a reduced Gal and/or sialic acid content containing 5% CO2 and incubated for four hours. Each
has been demonstrated by increasing binding to specific experiment included cells similarly cultured and incu-
lectins (Vicia Villosa) or increased asialo chains [21–23]. bated in the same medium and atmosphere, with no
A defective b1–3 galactosyltransferase activity has been additions (basal conditions).
detected in B lymphocytes from IgAN patients [24]. Human IgG (50 mg/mL, Cohn fraction II; Sigma) was
The functional significance of IgA altered glycosyla- tested as well.
tion and its potential to create mesangial injury is still
Enzymatic modification of IgA carbohydrate sideunexplored. We chose integrin expression as a clue marker
chain residuesof MC–matrix interactions since their reciprocal interac-
tions can regulate cell metabolism, proliferation, and To remove terminal sialic acid and expose the Gal
differentiation [25]. We employed human MCs and hu- residues, which become terminal, human IgA was incu-
bated for six hours at 378C with neuraminidase (fromman IgA to avoid differences in data interpretation from
Peruzzi et al: Integrins in IgAN 2333
Clostridium perfrigens; Sigma), using 0.1 U of enzyme umns (Economopack; Bio-Rad Laboratories, Hercules,
per mg of IgA in 25 mmol/L potassium acetate buffer CA, USA) and washed with 0.1 mol/L PBS, pH 7.4.
containing 0.1% bovine serum albumin (BSA), pH 4.5 Each of the five columns was loaded with 800 mL of
[27]. The effluent from a column of Sepharose cross- serum from four patients and four healthy controls. The
linked to Sambucus nigra lectin (Vector Laboratories, efflux was clamped, and the column was incubated for one
Inc., Burlingame, CA, USA) was deficient in terminal hour at room temperature. The columns were washed
Neu5Ac linked to Gal residues. This purification step for approximately three hours with flowing PBS, until
might leave some residual sialylation of GalNAc. the OD at 280 nm was negligible. Finally, the bound glyco-
A portion of the neuraminidase-treated IgA, nonad- proteins were eluted from the columns by washing with
herent to Sambucus nigra column, was subsequently in- solutions of the appropriate monosaccharide specific for
cubated for 12 hours at 378C with b-galactosidase (from each lectin: 0.1 mol/L Man, 0.1 mol/L GalNAc, 0.05 mol/L
bovine testis; Sigma) to remove terminal Gal and to Neu5Ac. The eluates were collected in 0.5 mL fractions,
expose GalNAc, which becomes terminal, at a ratio of and the absorbance values at 280 nm were considered
0.1 U of enzyme per 200 mg of IgA in 0.2 mol/L sodium to isolate the main peak of eluted proteins. The main
phosphate, 0.1 mol/L citrate buffer containing 0.1% peak in each column eluate was fractionated by high-
BSA, pH 4.5 [28]. The IgA bearing residual terminal performance liquid chromatography (HPLC) on a BioSil
galactose was removed by affinity chromatography using column (Biorad; Bio-Rad Laboratories), which separates
Sepharose cross-linked with Ricinus communis (Vector molecules in the 150 to 500 kD molecular mass range.
Laboratories), which recognizes terminal Gal. The isolated peaks at 250 to 500 kD in IgAN patients and
in controls were separately pooled for MC conditioning.Verification of IgA-bound oligosaccharide termination
Eluted material was assayed for IgA content by sandwich
Enzyme-linked immunosorbent assay (ELISA) plates ELISA. The same peak of purified polymeric IgA was
were coated with 10 mg/mL of unmodified or enzyme- also resolved by HPLC as a control. In all cases, the IgA
treated IgA in 0.015 mol/L carbonate buffer, pH 9.6, and concentration was adjusted before incubating the HPLC
unreacted sites were blocked with 1% BSA-phosphate- fractions with MC cultures.
buffered saline (PBS). After overnight incubation at 48C,
plates were washed with 0.1% BSA, 0.05% Tween 20, and Cell cultures
peroxidase-labeled Arachis hypogea (PNA)—specific for Human glomeruli were isolated from human cortical
the complete, galactosylated Galb1,3GalNAc—or Vicia
fragments obtained from uninvolved tissue of kidneys
villosa (VV)—specific for ungalactosylated GalNAc—
removed for cancer, and MCs were cultured as pre-
lectins (5 mg/mL) both from Sigma, were added for one
viously described [29]. Cells were grown in RPMI 1640hour at room temperature. Next, after three washes,
(Sigma) supplemented with 20% fetal calf serum (Sigma)—the enzyme substrate phenylendiamine dihydrochloride
final concentration 20 mg/mL fibronectin—2 mmol/L glu-(Sigma) 0.4 mg/mL in 0.03% vol/vol hydrogen peroxide,
tamine, 50 U/mL penicillin, and 50 mg/mL streptomycin0.1 mol/L disodium hydrogen phosphate, and 0.05 mol/L
in a 5% CO2 humidified atmosphere. Before employ-citric acid monohydrate were added. The results of this
ment, cells were checked for factor VIII and cytokeratincolorimetric reaction were read at 490 nm at the end of
negativity and actin-positive staining.the linear phase.
Antibodies to integrinsIgA glycoforms from sera of patients with IgAN
The primary monoclonal antibodies (mAbs) used inFractions from sera of IgAN patients containing IgA
this study were anti-a3 (F2; donated by L. Zardi, IST,with various glycosylation patterns were isolated by af-
Genoa, Italy), anti-b1 (MAR4; donated by S. Me´nard,finity chromatography using columns of lectins immobi-
Istituto Nazionale Tumori, Milan, Italy), anti-b3 (VIPl-2;lized on Sepharose. Sepharose 4B CNBr-activated col-
a gift of W. Knapp, Institute of Immunology, Universityumns (Pharmacia, Uppsala, Sweden) were prepared as
of Vienna, Austria), anti-b4 (AA3; donated by V. Qua-recommended by the manufacturer. Selected lectins were
ranta, Scripps Research Institute, La Jolla, CA USA),cross-linked to Sepharose by incubating in 0.1 mol/L
anti-a2 (Gi9; Immunotech, Marseille, France), anti-a5NaHCO3, 0.5 mol/L NaCl buffer at 48C for 12 hours.
(SAM-1; Immunotech), anti-b5 (IA9; from M. Hemler,The lectins employed included the following: Canavalia
Dana Farber Cancer Institute, Boston, MA, USA), anti-avensiformis (Con A), specific for mannose (Man) group;
(P3G8; Chemicon, Temecula, CA, USA) and anti-avb3Glycine maximus (SBA), specific for N-acetylgalactos-
(MS 3 Hu integrin av, recognizing the avb3 receptor;amine/galactose (GalNAc-Gal) group; and Limulus poly-
Chemicon). As control, irrelevant antibodies were usedphemus (LPA), specific for sialic acid (Neu5Ac 2,6 Gal
NAc) groups. The gel beads were packed in 5 mL col- (Table 1).
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Table 1. Monoclonal antibodies employed in this study
Clone Specificity Source
F2 Anti-a3 L. Zardi, IST, Genoa, Italy
MAR4 Anti-b1 S. Me´nard, Istituto Nazionale Tumori, Milan, Italy
VIPI-2 Anti-b3 W. Knapp, Immunology Institute, University of Vienna, Austria
AA3 Anti-b4 V. Quaranta, Scripps Research Institute, La Jolla, CA, USA
Gi9 Anti-a2 Immunotech, Marseille, France
SAM-1 Anti-a5 Immunotech, Marseille, France
IA9 Anti-b5 M. Hemler, Dana Farber Cancer Institute, Boston, MA, USA
P3G8 Anti-av P3G8, Chemicon, Temecula, CA, USA
MS3Hu Anti-avb3 MS3Hu integrin-av, Chemicon, Temecula, CA, USA
Immunofluorescence USA) set to analyze 5000 cells per sample. Data were
elaborated by the Immuno-4 program (Coulter).After detachment with 0.05% trypsin-0.02% ethylene-
diaminetetraacetic acid (EDTA; Sigma), 5 3 104 cells
Quantitation of integrin receptors
were plated into each well of 24-well plates (Costar
To quantitate the average number of integrin recep-Corp., Cambridge, MA, USA) containing 1.4 cm2 round
tors per MC, the Quantum (TM) 27 R-phycoerythrin (PE)-glass cover slips. Cells were incubated for eight hours in
conjugated microbead kit (Flow Cytometry Standardcomplete medium; next, after several washes in PBS,
Corp., San Juan, Puerto Rico) was used [31]. This containsthey were fixed in 3% paraformaldehyde, 2% sucrose in
a set of calibrated standards, with four populations of PE-PBS, pH 7.6, for 10 minutes at room temperature. After
conjugated microbeads displaying graded and predeter-rinsing in PBS, cells were permeabilized by soaking cover
mined fluorescence intensity [expressed in terms of theslips for three to five minutes at 08C in HEPES-Triton
number of molecules of equivalent soluble fluorochromesX-100 buffer (20 mmol/L HEPES, pH 7.4, 300 mmol/L
(MESFs)] and one reference blank population. Using thissucrose, 50 mmol/L NaCl, 3 mmol/L MgCl2, and 0.5%
method, the relative channel number obtained by flowTriton X-100). Indirect immunofluorescence was per-
cytometry analysis of a cell population is directly trans-formed as previously reported [30]. Briefly, the primary
formed into the number of MESFs. The linear regressionAb (at the concentration of 10 mg/mL) was layered onto
equation, correlating the channel number with the spe-the fixed and permeabilized cells and incubated in a
cific MESF value, was calculated using specific softwarehumid chamber for 30 minutes at 378C. After rinsing,
(Quickcal V2.0; Flow Cytometry Standard Corp.). Resultscover slips were incubated in the appropriate rhodamine-
express the mean MESFs 6 SD of four experiments.tagged secondary antibody (Dakopatts, Copenhagen, Den-
The number of MESFs corresponds to the number ofmark) for 30 minutes at 378C in the presence of 2 mg/mL of
fluorescent molecules detected on the surface of MCs,fluorescein-labeled phalloidin (Sigma). Cover slips were
indicating the number of integrin receptors.mounted in Mowiol 4-88 (Hoechst AG, Frankfurt/Main,
Germany) and observed in a Zeiss Axiophot photomi-
Indirect immunoperoxidase techniquecroscope equipped with epifluorescence lamp and plana-
Mesangial cells, grown in chamber slides, were stainedpochromatic oil immersion lenses. Fluorescence images
using a standard protocol. MCs in basal conditions andwere recorded on Kodak T-Max 400 film exposed at
conditioned by aberrantly glycosylated IgA were snap1000 ISO and developed in T-Max Developer for 10
frozen in isopentane precooled in liquid nitrogen. En-minutes at 208C.
dogenous peroxidase activity was inhibited by incubation
Flow cytometry analysis for 30 minutes in 0.025% H2O2 in methanol. Endogenous
biotin activity was inhibited by sequential 30-minute ex-For this analysis, 5 3 104 cells were allowed to adhere
posures to avidin D and biotin blocking solutions (Vectorto 75 cm2 flasks for eight hours at 378C; then the medium
Laboratories Inc.). Following another wash, cells werewas substituted with complete medium containing one
incubated in 0.005% biotin in PBS, washed again, andof the various stimuli noted previously in this article.
then overlaid with 10 mg/mL primary antibody (anti-a5,Flasks were incubated for four hours at 378C, and then
anti-b1, anti-b5, and anti-avb3) for 30 minutes in a mois-cells were detached in 1 mmol/L EDTA, washed in PBS,
ture chamber at room temperature. Slides were rinsedand incubated with the primary Ab (10 mg/mL) at 48C
in PBS, incubated for 30 minutes at room temperaturefor 30 minutes. After two washes with PBS, MCs were
with biotinylated rabbit anti-mouse IgG, rinsed again,incubated at 48C for 30 minutes with a FITC-rabbit anti-
and incubated in avidin-biotin-peroxidase complex (Vec-mouse antibody (Biosoft, Varilhes, France), rinsed in
tor Laboratories Inc.). Finally, slides were developed forPBS, and analyzed after fixation with 1% paraformalde-
hyde, in an EPICS XL counter (Coulter, Hialeah, FL, 5 to 10 minutes with a solution of 0.075% diaminobenzi-
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Fig. 1. Immunofluorescence staining of cul-
tured human mesangial cells (MCs). The cells
were stained with mouse monoclonal antibod-
ies to av, followed by incubation with an appro-
priate rhodamine-tagged secondary antibody.
The integrin chains were found in patches at
the end of actin fibrils, counterstained with
fluoresceinated phalloidin. These clusters of
av correspond to focal contacts. In other views
(not shown), av colocalizes with vinculin. Orig-
inal magnification 3630.
dine and 0.015% H2O2 in 0.05 mol/L Tris. Cells were mg/mL aggregated IgA. We observed that av expression
peaked between four and six hours of incubation withcounterstained with Meyer’s hematoxylin (Zymed, San
Francisco, CA, USA), mounted in Cleariumt (Surgi- all stimuli, and no modifications were observed in the
following hours until 24 hours. Hence, an incubationpath, Canada), and examined with a Zeiss Axiophot
photomicroscope equipped with 316 and 363 plana- time of four hours was adopted in each experiment.
Integrins in cultured MCs were quantitated in flowpochromatic lenses. To control for specificity of the im-
munoperoxidase staining, parallel MC preparations were cytometry by means of calibration beads, correlating the
fluorescence intensity with the number of fluorochromesoverlaid with 10 mg/mL of a murine monoclonal IgG
antibody specific for Ewing’s sarcoma cells (Signet Labo- (MESFs), hence expressing the number of cell surface
molecules. This technique has been proposed to quanti-ratories, Dedham, MA, USA) as a primary antibody and
subsequently were incubated with all of the same steps tate the receptor molecules/cell, providing data superim-
posable to conventional radiobinding assays [31]. Evenused to detect the specific primary antibody.
considering the basal value of MESFs in resting MCs as
Statistical analysis an approximation of the true number of integrins/cell,
the data allowed the evaluation of the modulation in-Values are expressed as means 6 SD. A comparison
between group means was performed using Student’s duced by aberrantly glycosylated and macromolecular
IgA, which was the aim of the present study.t-test. P values of less than 0.05 were considered statisti-
cally significant. Pearson’s correlation and linear regres- The intensity of av expression on MCs increased after
sion analysis were used to calibrate receptor analysis by incubation with mesangial matrix components. After in-
flow cytometry, as detailed previously in this article. cubation with fibronectin or type IV collagen, the modal
fluorescence intensity and the mean channel number
shifted to the right on a log scale (Fig. 2A) relative toRESULTS
the modal fluorescence intensity and the mean channel
Integrin expression in cultured MCs and modulation number seen with cells in medium alone (basal). Simi-
of the av chain by purified matrix proteins and IgA larly, the addition of either form of IgA to the culture
medium intensified the expression of av on MCs (Fig.Immunofluorescence staining of cultured human MCs
showed strong expression of av (Fig. 1), b3, and a3 integrin 2B). The calculated number of av receptors per cell (ex-
pressed in MESFs) was nearly tripled after incubationchains, and to a lesser extent, b1, trace amounts of a5
were detected. Conversely, MCs were negative for a2, with fibronectin or collagen: basal MCs had 822 6 55
MESFs/cell; MCs conditioned with fibronectin 0.5 timesb4, and b5 (data not shown). Flow cytometry revealed
that 95 6 0.7% of cultured MCs were positive for av in the basal conditions had 2426 6 498 MESFs/cell (P ,
0.025 vs. basal), and MCs incubated with type IV collagenassociation with b3. In preliminary studies, we performed
a time course of av expression on MCs after incubation had 2217 6 401 MESFs/cell (P , 0.025 vs. basal). The
supplementation of culture medium with fibronectinwith 10 mg/mL of mesangial matrix components or 50
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Fig. 2. Flow cytometry analysis of av expres-
sion on human cultured mesangial cells (MCs).
(A) Cells were studied in unconditioned me-
dium (basal) and after supplementation of cul-
ture media with type IV collagen (Coll IV) or
fibronectin (both 10 mg/mL). (B) Cells under
basal conditions are compared with cells pre-
incubated with either polymeric IgA (pIgA)
or aggregated polymeric IgA (aIgA). For each
of the three superimposed histograms, the
number of cells at each level of fluorescence
is plotted on an ordinate against the same ab-
scissas log fluorescence intensity. The most
frequent (peak) fluorescence intensity under
basal conditions is 0.66 (mean channel number
1.08). Cells preincubated with either extracel-
lular matrix component (A) showed peak flu-
orescence levels of 1.9 (collagen IV) or 1.8 (fi-
bronectin; mean channel number 2.25 and 2.38,
respectively), whereas incubation with either
preparation of IgA (B) resulted in peak fluo-
rescence levels of 2.0 (pIgA) or 1.4 (aIgA; mean
channel number 1.85 and 2.04, respectively).
concentrations up to 1.5 times the usual medium content value was higher than what was observed with serum
fractions isolated from healthy controls (536 6 11 MESFs/led to a further increase in av receptors per cell (2850 6
432 MESFs/cells). cell). It should be considered that the LPA affinity chro-
matography separates Neu5Aca2,6GalNAc-rich mole-Mesangial cells conditioned with polymeric IgA had
1715 6 233 MESFs/cell, and with aggregated IgA 1961 6 cules, hence also IgA molecules truncated because of
deficient b1,3 Gal transferase [24].224 MESFs/cell (both P , 0.01 vs. basal; Fig. 3). The
Serum fractions from patients with IgAN eluted fromculture of MCs with 50 mg/mL aggregated IgA in addi-
Con A columns by Man, and therefore rich in IgA glyco-tion to 10 mg/mL fibronectin further increased the integ-
form presenting terminal Man residues, increased therin expression in comparison to aggregated IgA alone
expression of av integrins by cultured MCs (1934 6 261(2552 6 235 MESFs/cell).
MESFs/cell, P , 0.02 vs. basal) and provided data sig-
Differential modulation of av by distinct nificantly higher than serum fractions similarly isolated
glycoforms of IgA from healthy controls (1004 6 22 MESFs/cell, P , 0.05
vs. IgAN data). The coincubation of MCs with Man alsoSerum IgA glycoforms isolated in IgAN patients by
SBA affinity chromatography and hence exposing termi- augmented av density (1690 6 153 MESFs/cell, P , 0.02
vs. basal; Fig. 4).nal GalNAc residues increased the expression of av in-
tegrin on cultured MCs (1741 6 335 MESFs/cell, P , To examine the role of the protein-bound oligosaccha-
rides in the modulation of av integrin expression by IgA0.05 vs. basal; Fig. 4). This effect was significantly higher
than what was observed after incubation of serum fractions further, we generated distinct glycoforms of IgA by enzy-
matic hydrolysis of selected saccharide residues fromfrom healthy controls (953 6 33 MESFs/cell vs. IgAN,
P , 0.05). Free GalNAc had an enhancing effect (2660 6 purified normal polymeric human IgA.
The effects of enzymatic hydrolysis of sialic acid and171 MESFs/cell, P , 0.005 vs. basal; Fig. 4). Conversely,
free sialic acid strongly depressed av expression on MCs galactose to generate desialylated and desialylated/dega-
lactosylated IgA were confirmed by reciprocal changes(256 6 6 MESFs/cell, P , 0.05). The fractions isolated in
IgAN patients by LPA, specific for terminal Neu5Ac2,6 in the binding of the treated IgA to PNA and to VV
lectins. Neuraminidase-treated IgA bound 2.3-fold morebound to GalNAc, failed to significantly modify the num-
ber of integrins/MCs in comparison to basal conditions PNA and 2.6-fold less VV than IgA treated sequentially
with neuraminidase and b-galactosidase.(752 6 254 MESFs/cell, P 5 NS; Fig. 4); however, this
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Fig. 3. Quantitation of av integrin chains on
cultured human MCs by flow cytometry. Cells
maintained in unconditioned medium (basal)
or after incubation with polymeric IgA (pIgA),
aggregated IgA (aIgA), in vitro desialylated
(deSia) IgA, or desialylated/degalactosylated
(deSia/deGal) IgA were studied by flow cy-
tometry, and the number of MESFs/cell, indi-
cating the number of sites/cell calculated as
detailed in the text. Data are the mean 6
SD of four separate experiments. Note that
polymeric IgA promote a doubling of av den-
sity on the cell surface, while the macromolec-
ular aggregation does not further increase the
integrin expression. Desialylated IgA induce
an increase in av density similar to polymeric
IgA. Conversely, desialylated/degalactosylated
IgA promote a striking increase in av expres-
sion, which was significantly higher than after
incubation with polymeric IgA (†P , 0.01).
*P , 0.025 vs. basal conditions. **P , 0.001
vs. basal conditions.
IgA desialylated in vitro increased the expression of
av on cultured MCs, as observed by immunoperoxidase
staining, and desialylated/degalactosylated IgA strongly
enhanced such expression (Fig. 5). The number of av
receptors per cell significantly increased to 3850 6 143
MESFs after incubation of MCs with desialylated/dega-
lactosylated IgA (P , 0.001 vs. basal conditions and P ,
0.01 vs. untreated polymeric IgA; Fig. 3).
The coincubation of MCs with 50 mg/mL of desialy-
lated IgA or desialylated/degalactosylated IgA in addi-
tion to 10 mg/mL fibronectin failed to increase integrin
expression further, as it was blunted in comparison to
what found by incubating one probe at once (desialylated
IgA plus fibronectin, 16% decrease of desialylated IgA
alone; desialylated/degalactosylated IgA in addition to
fibronectin, 49% decrease of desialylated/degalactosy-
lated IgA alone).
Fig. 4. Effect of glycan on the density of av integrin chains on cultured Human IgG was ineffective in modifying the integrin
human MCs by flow cytometry. Cells were studied in unconditioned expression on MCs.
medium (basal) or with fractions of IgA from the serum of IgAN
patients and healthy controls isolated by affinity chromatography on
Glycine maximus lectin (IgA-SBA) or lectin from Limulus polyphemus
DISCUSSION(IgA-LPA), or on Canavalia ensiformis (IgA-ConA) or with an appro-
priate simple sugar such as N-AcetylGalactosamine (GalNAc), N-acetyl Human MCs in culture strongly express avb3 and, at aneuraminic acid (Neu5Ac), or mannose (Man). Exposure of MCs to
lower intensity, a3b1 receptors for extracellular matrix [2].IgA, which contains terminal GalNAc (IgA-SBA), or terminal Man
(IgA-ConA) or to the corresponding simple sugars, elicits a doubling Shikata et al reported markedly increased expression of
or trebling of the expression of av receptors on MCs, compared with b1, av, and b3 chains in renal tissue from IgAN patientscells under basal conditions (data are expressed in MESF/cell as in Fig. 3).
relative to normal kidneys, in which only trace amounts ofFractions in patients were more effective in eliciting av integrin expres-
sion than those similarly isolated in controls. Statistical differences these integrins are detectable by immunofluorescence [12].
versus *basal conditions and †fractions isolated in healthy controls, as Unpublished observations of our group were largely con-detailed in the text. Symbols are: (h) sugar; ( ) IgAN; (j) healthy
controls. firmatory (abstract; Emancipator et al, J Am Soc Nephrol
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on the modulation of MC av chain, which coprecipitates
with b3 to form the major receptor for vitronectin, fibro-
nectin and fibrinogen, thrombospondin, and von Wille-
brand factor, recognizing a specific RGD sequence [3, 4].
Integrin-ligand binding and activation initiate the intra-
cellular signals that regulate adhesion, spreading, and mi-
gration of several distinct cell lineages, including MCs [5–8].
Coincubation of MCs with supraphysiological amounts
of matrix components enhanced a significant up-regula-
tion of av expression. A different reactivity could have
been expected for fibronectin, which is a natural ligand
for avb3 and collagen IV, which selectively binds b1 integ-
rins [4]. However, integrins can be modulated by path-
ways independent from receptor ligation, as by cytokines
[34, 35]. Hence, the binding of collagen IV to b1 integrins,
by activating the cytoplasmic tail, is expected to regulate
the formation of focal contacts and stress fibers for sus-
tained adhesion, which might lead to hyperexpression
of other integrins [34].
Focusing on the modulation of MC integrins by aber-
rantly glycosylated IgA and macromolecular IgA, we
employed human cells and immunoglobulins in order to
avoid variations in IgA biology from laboratory animals
to humans [reviewed in 16]. We used human secretory
IgA isolated from cholostrum, which is the major source
of almost pure polymeric IgA (96% of secretory IgA are
polymeric) [16]. Polymeric IgAs are increased in circula-
tion in IgAN patients and are dominant in mesangial
IgA deposits [36]. Moreover, polymeric IgA in form of
complexes reproduce in experimental rodents the IgAN
nephritogenesis [37]. Polymeric IgA and heat-aggregated
IgA were found to enhance strongly the reactivity of
murine MCs [38, 39] and enhance in human MC nuclear
factor-kB (NF-kB) transcription [40]. Secretory IgAs
have several properties of polymeric IgA, including the
high capacity to aggregate [41] and to activate the com-
plement alternative pathway [42]. Cholostral IgA is pro-
Fig. 5. Immunoperoxidase staining of av in cultured human MCs. Com- vided with additional glycated chain-linked sugars, whichpared with cells cultured under basal conditions (a) and cells preincu-
might further enhance the consequences of IgA glycationbated with desialylated IgA (b), cells preincubated with enzymatically
generated asialo-agalactosyl-IgA (c ) exhibited clearly more intense [16]. On the other hand, it is unlikely that the use of
staining for av. For these preparations, the appropriate reciprocal changes secretory IgA modify the potential significance of ourin IgA glycosylation were verified by lectin affinity assay: asialo-IgA
results in giving new insight into this aspect of IgANbound 2.3-fold better to Arachis hypogea lectin (specific for asialo-
oligosaccharides) than doubly enzyme-treated IgA, whereas binding to nephritogenesis.
Vicia Villosa lectin (specific for terminal GalNAc) was 2.6-fold less. We also tested heat-aggregated polymeric IgA, which
are likely to be of a very large size. These polymeric IgA
aggregates possibly mimic large immune complexes, which
escape the hepatic clearance because they fail to enter8:84, 1997). Expanded mesangial regions were strongly
positive for avb3 and its ligands, fibronectin, and vitronec- the space of Disse and mimic deposited IgA rearranged
electron-dense deposits.tin. Immunoelectron microscopy confirmed a selective
MC av expression associated with mesangial deposits We detected a clear enhancement of av by the interac-
tion between macromolecular IgA and MCs. Besides,[12]. Other reports indicated increased avb3 mesangial
expression in highly proliferative IgAN [32], suggesting this effect was elicited also by the oligosaccharide com-
position of the IgA. Fca receptors expressed on rat MCsa role of this integrin in phagocytosis of apoptotic cells
in the inflamed glomerulus [33]. are heavily glycosylated [38]. Moreover, in rodents, IgA
interacts with asialoglycoprotein receptors on MCs [43],Based on its possible involvement in IgAN, we focused
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a surface lectin specific for galactose residues, suggesting It is tempting to speculate that the binding of aber-
rantly glycosylated IgA with MC IgA-specific receptorthe possibility of interactions mediated by carbohydrate
bindings, including desialylated IgA. Indeed, in some enhances integrin expression as a result of a broad-spec-
trum cell activation with production of transcriptionalstudies, desialylated IgA were found to bind more effi-
ciently than native IgA to rat MCs enhancing cell activa- factors, leading to the release of different mediators
(Amore et al, manuscript submitted). The interaction oftion with release of oxygen free radicals [38]. In humans,
the matter is controversial, since human MCs constitu- IgA with Fca receptors of human MCs activates tran-
scription factor NF-kB leading to enhanced proinflam-tively express Fca receptor, but this is not coincident
with the CD89 molecule expressed on human monocytes, matory cytokine production and superoxide generation
[40]. In turn, several cytokines, including transformingand human MCs lack ASGPR [44]. Hence, the possible
interferences of aberrantly glycosylated IgA with its re- growth factor-b, basic fibroblast growth factor, platelet-
derived growth factor, and epidermal growth factor, haveceptor are still speculative.
We found that some sugars represented in the inner been shown to modulate integrin expression in different
cell types [34, 47], hence supporting the possibility thatpart of the carbohydrate side chains of IgA (Man and
GalNAc) enhance av expression, while the external ter- the increased av integrin expression in MCs coincubated
with aberrantly glycosydated IgA or macromolecularminal residue (Neu5Ac) depressed it. These observa-
tions were supported by the finding that in vitro desialy- IgA could be mediated as well by cytokine release.
In conclusion, we found that truncation of terminallated/degalactosylated human polymeric IgA strongly
enhanced integrin expression. Of interest, the effect of sugars of IgA glycan chains as well as macromolecular
IgA up-regulated the expression of avb3 receptors inthe removal of both sialic acid and Gal was much more
evident than the simple desialylation. As reported pre- cultured MCs. We speculated that integrin expression
may modulate cell proliferation, apoptosis with regres-viously in this article, the recent literature suggests an
increased circulation in IgAN of IgA bearing O-linked sion of cell infiltration, and phagocytosis of IgA deposits,
regulating mesangial hypercellularity and matrix accu-carbohydrate chains with greater exposure of GalNAc.
From our experiments, the exposure of GalNAc after the mulation. Moreover, it may favor MC contraction and
transmission of contractile forces to the capillary wall,treatment of various glycosydases was mostly effective in
increasing the number of avb3 receptors on MCs. modifying intraglomerular hemodynamics. Such proc-
esses may play an important role in the pathogenesisWe observed that the coincubation of polymeric IgA
with fibronectin increased the av expression. Conversely, and evolution of IgAN.
we detected a blunted effect when desialylated and desia-
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